Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Carcinoma, Transitional Cell 2Urologic Neoplasms 1Squamous Cell Lung Cancer 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 2bleomycin A6 1apatorsen 1Pemetrexed 1Injections 1Gemcitabine 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Squamous Cell Lung Cancer × apatorsen × Clear all
NCT02423590 2017-08-22

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers

Queen Mary University of London

Phase 2 Unknown
140 enrolled
Thoracic

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡